DANIEL ERNESTO
CASTELLANO GAUNA
Profesor asociado de Ciencias de la Salud
Technical University Munich
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Technical University Munich (3)
2014
-
Phase II results of dovitinib (TKI258) in patients with metastatic renal cell cancer
Clinical Cancer Research, Vol. 20, Núm. 11, pp. 3012-3022
-
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer
Journal of Clinical Oncology, Vol. 32, Núm. 2, pp. 76-82
2013
-
Phase i study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma
Clinical Cancer Research, Vol. 19, Núm. 5, pp. 1257-1268